Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

When it comes to insurance claims, there are some that compounders can face above and beyond what other pharmacists do—and boy, are they costly (they don’t help your reputation much, either).

Thanks to our friends at Pharmacists Mutual, we can tell you and your team members what they are and how to avoid them.

Please join us for a webinar, Pharmacists Mutual’s Most “Popular” Insurance Claims in Compounding (and how not to be one of them) this coming Tuesday, May 24 from 2:00pm–3:00pm EDT.

Webinar details
Tuesday, May 24
2:00pm – 3:00pm EDT
$25
To register, please click here.

Note: This webinar does not offer CE credit